Deutsch



Participate in a Clinical Study

Would you like to contribute to advancing healthcare by participating in a study at the CRC Hannover? Our team conducts early-phase clinical trials with state-of-the-art methods and leading-edge equipment. Get involved in medical research and help create the future of science!

Get more information (in German)

National Cohort at the HZI

“Working together for a healthier Germany” is the main idea behind the German National Cohort, Germany’s largest ongoing epidemiological study, in which the HZI is a partner. A total of around 10,000 participants from the greater Hannover area will be examined and interviewed at the CRC Hannover.

To German National Cohort Study

News

FUNCTIONAL MRI STUDY CONFIRMED RELIABILITY OF ARTERIAL SPIN LABELING

November 24, 2017

In a clinical study for method validation, performed in close collaboration with the Institute for Radiology of the Hannover Medical School, scientists were able to demonstrate that functional MRI with arterial spin labeling is a reliable method for quantification of kidney perfusion.

read more

Phase-I drug interaction study in Crohn’s disease patients initiated

February 2, 2018

In close collaboration with the Clinic for Gastroenterology, Hepatology and Endocrinology at the Hannover Medical School, the potential of ustekinumab to interfere with the pharmacokinetics of midazolam, warfarin, omeprazole, dextromethorphan, and caffeine is being explored at the CRC Hannover in a phase-I study with patients with moderate to severe Crohn's disease.

read more

New sleep laboratory: first study with a new antidepressant drug

January 25, 2018

Fraunhofer ITEM has extended the diagnostic possibilities in its clinical research by setting up a sleep laboratory with 4 beds in the phase-I unit of the Clinical Research Center Hannover.

read more

Innovative clinical study: a successful step in COPD research

February 22, 2018

Great success in COPD research: An innovative clinical study performed by Fraunhofer ITEM has shown the drug under investigation to improve not only lung function in COPD patients, but to have a significantly positive effect on their heart function as well. The study investigated a combination drug from Novartis Pharma AG (indacaterol/glycopyrronium) that has already been approved for COPD treatment. The results were published in the renowned journal "The Lancet Respiratory Medicine".

read more

Events

ATS International Conference 2018

This year's annual conference of the American Thoracic Society (ATS) will be held from May 18 to 23 in San Diego, CA (USA). The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders.

go to event